Evidence map›Paper›PMID 20338878›Full record

ArticleNucleic acids research2010

Duplex structural differences and not 2'-hydroxyls explain the more stable binding of HIV-reverse transcriptase to RNA-DNA versus DNA-DNA.

Jeffrey T Olimpo, Jeffrey J DeStefano

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jeffrey T OlimpoDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Jeffrey J DeStefano
University of Maryland, College Park · US

Funding

MECHANISM OF RECOMBINATION BY HIV REVERSE TRANSCRIPTASER01GM051140 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI DESTEFANO, JEFFREY J · 2000 to 2011
$3.0M
MECHANISM OF RECOMBINATION BY HIV REVERSE TRANSCRIPTASER29GM051140 · NIGMS · UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS · PI DESTEFANO, JEFFREY J · 1994 to 1998
–
NIGMS NIH HHS GM051140NIGMS NIH HHS R01 GM051140
6 · The paper itself

Abstract

Human immunodeficiency virus reverse transcriptase (HIV-RT) binds more stably in binary complexes with RNA-DNA versus DNA-DNA. Current results indicate that only the -2 and -4 RNA nucleotides (-1 hybridized to the 3' recessed DNA base) are required for stable binding to RNA-DNA, and even a single RNA nucleotide conferred significantly greater stability than DNA-DNA. Replacing 2'- hydroxyls on pivotal RNA bases with 2'-O-methyls did not affect stability, indicating that interactions between hydroxyls and RT amino acids do not stabilize binding. RT's K(d) (k(off)/k(on)) for DNA-DNA and RNA-DNA were similar, although k(off) differed almost 40-fold, suggesting a faster k(on) for DNA-DNA. Avian myeloblastosis and Moloney murine leukemia virus RTs also bound more stably to RNA-DNA, but the difference was less pronounced than with HIV-RT. We propose that the H- versus B-form structures of RNA-DNA and DNA-DNA, respectively, allow the former to conform more easily to HIV-RT's binding cleft, leading to more stable binding. Biologically, the ability of RT to form a more stable complex on RNA-DNA may aid in degradation of RNA fragments that remain after DNA synthesis.

Indexed as

Avian Myeloblastosis VirusDNAHIV Reverse TranscriptaseKineticsMoloney murine leukemia virusNucleotidesProtein BindingRNAUridineDNAHIV Reverse TranscriptaseNucleotidesRNAUridine

Identifiers

PMID20338878
PMCPMC2910049
OpenAlexW2042064699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.